| 发明名称 |
Pyrimidin-4-yl)oxy)-1h-indole-1-carboxamide derivatives and use thereof |
| 摘要 |
This invention relates to certain metabolites of N-(1-methyl-5-(trifluoromethyl)-1H-pyrazol-3-yl)-5-((6-((methyl-amino)methyl)pyrimidin-4-yl)oxy)-1H-indole-1-carboxamide In particular, the present invention relates to pharmaceutical compositions comprising these metabolites, as well as processes for their preparation and their use in the treatment of diseases. |
| 申请公布号 |
US9604969(B2) |
申请公布日期 |
2017.03.28 |
| 申请号 |
US201414891674 |
申请日期 |
2014.05.16 |
| 申请人 |
NOVARTIS AG |
发明人 |
Glaenzel Ulrike;Nufer Robert |
| 分类号 |
A01N43/54;C07D239/42;C07D401/04;C07D403/14 |
主分类号 |
A01N43/54 |
| 代理机构 |
|
代理人 |
Roth Joshua |
| 主权项 |
1. A method for treating macular degeneration, diabetic retinopathy, retinopathy, or retinitis pigmentosa in a subject in need thereof, wherein said method comprises administering to the subject a compound selected from the group consisting of: |
| 地址 |
Basel CH |
